Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2010
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136144A1 Substituted piperidines
12/02/2010WO2010136128A1 Substituted piperidines
12/02/2010WO2010136127A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010US20100305317 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305176 (s,r.)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent
12/02/2010US20100305174 Novel Heterocyclic Derivatives
12/02/2010US20100305128 Pyrimidinyl-Thiophene Kinase Modulators
12/02/2010US20100305126 Pyrimidine Inhibitors of Kinase Activity
12/02/2010US20100305125 Salt of abt-263 and solid-state forms thereof
12/02/2010US20100305124 Acylated Aminopyridine and Aminopyridazine Insecticides
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305121 Novel antagonists of the human fatty acid synthase thioesterase
12/02/2010US20100305120 Compounds for treating muscular dystrophy
12/02/2010US20100305119 Method for the treatment of anthrax infections
12/02/2010US20100305118 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305112 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305099 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305095 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
12/02/2010US20100305092 Triazole oxadiazoles derivatives
12/02/2010US20100305088 INHIBITORS OF THE CHEMOKINE RECEPTOR CxCR3
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100304074 Indolium compound and optical recording material containing the same
12/02/2010US20100303926 Organic compounds
12/02/2010CA2769769A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010CA2763633A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763400A1 Substituted piperidines
12/02/2010CA2763370A1 Substituted piperidines
12/02/2010CA2763351A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
12/02/2010CA2763008A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2256116A2 Aryl sulfonamides
12/01/2010EP2256115A1 Heteromonocyclic compound and use thereof
12/01/2010EP2256114A1 Amide derivative and pharmaceutical composition containing the same
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254878A1 Aldh-2 inhibitors in the treatment of addiction
12/01/2010EP2254863A1 Pesticidal condensed - ring aryl compounds
12/01/2010EP2125798B1 A method for the preparation of zolmitriptan
12/01/2010EP1869020B1 Heteroaryl urea derivatives useful for inhibiting chk1
12/01/2010EP1590336B1 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN1886133B Indole compounds
12/01/2010CN101903380A 5-aminocyclylmethyl-oxazolidin-2-one derivatives
12/01/2010CN101903379A Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas
12/01/2010CN101903378A Aminotriazole derivatives
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903372A Heteroaryl derivatives as orexin receptor antagonists
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101903353A Aminopyrazole derivatives
12/01/2010CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101903310A Process for producing organic compound and organic compound obtained by the same
12/01/2010CN101902915A Insecticidal compounds
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101899010A Quinazol derivative, preparation method and application thereof
12/01/2010CN101450945B Method for producing furazolidone large particle crystal
12/01/2010CN101228207B Thermosetting compound, composition containing the same, and molding
12/01/2010CN101115737B Novel salt form of a dopamine agonist
11/2010
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842814 deprotecting, aldol condensations, cleaving double bonds, deesterifying, alcoholization, oxidation with organometallic, lactonization
11/30/2010US7842695 such as 1-{1-[5-(4-Fluorophenyl)pyridin-2-yl]-5-furan-2-yl-1H-pyrazol-4-ylmethyl}-4-methylpiperazine, exhibiting selective serotonin receptor antagonistic properties, used for the prophylaxis and/or treatment of psychoses, neurological disorders, amyotrophic lateral sclerosis, eating and vision disorders
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010US7842688 Organic compounds
11/30/2010US7842686 Calcitonin gene-related peptide (CGRP) receptor antagonists, such as 2-(2-Butyl-3-oxo-2H-benzo[b][1,4]thiazin-4(3H)-yl)-N-(2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-indene]-5'-yl)acetamide, used as analgesics
11/30/2010CA2624621C Pyrazine derivatives
11/30/2010CA2607499C Histamine-3 receptor antagonists
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2515151C Non-nucleoside reverse transcriptase inhibitors
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010135429A2 Compositions for modulating a kinase cascade and methods of use thereof
11/25/2010WO2010134478A1 Pyrimidine compound and its use in pest control
11/25/2010WO2010133885A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010WO2010132951A1 Oligothiophenes and uses thereof in photovoltaic devices
11/25/2010WO2010081034A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010US20100298565 Processes for the Preparation of Paliperidone and Pharmaceutically Acceptable Salts Thereof and Intermediates for Use in the Processes
11/25/2010US20100298560 process for preparing mycophenolate mofetil
11/25/2010US20100298558 Substituted dihydroazole compound and pest control agent
11/25/2010US20100298392 Isoindoline Derivatives For The Treatment Of Arrhythmias